EBD Group

EBD Group is the leading partnering firm for the global life science industry.

EBD Group's overriding mission is to facilitate connections across the life science value chain. Our range of partnering conferences has grown to be one of the largest and most productive conference platforms in the industry. Each one of our seven landmark events held in key markets around the world is powered by partneringONE®, that enables delegates to efficiently identify and engage with new op

portunities via one-to-one meetings. Furthermore, with our EBD Academy courses professionals enhance key skills and competencies that enable them to successfully navigate biopharma business development, with a combination of in-person and online courses throughout the year. Tune into EBD Group’s Partnering Insight for timely coverage of news that influences the business strategies of the life science industry. For more information, please visit www.ebdgroup.com

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Innovation Organization (BIO).
- BioPharm America™, the fastest growing partnering event in North America.
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton.
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO.
- ChinaBio® Partnering Forum, a biotech/pharma partnering conference in China.
- Asia Bio Partnering Forum, a partnering forum focused across the Asia Pacific region. EBD Group has three decades of experience in organizing first-in-class partnering events.

25/03/2026

🌟 Join the Conversation: The New Partnering Playbook in Biotech! 🌟

Partnerships are evolving in the biotech world! It’s no longer just about one-off asset deals. In today’s landscape of tighter capital and increased selectivity, companies are building broader ecosystem alliances with VCs, academic centers, and incubators.

📅 Plenary Session
🗓 Tuesday, 28 April 2026
⏰ 11:00 - 12:00 CT (China Time, GMT+08:00)

💡 Key Discussion Points:

How are companies leveraging incubators, venture studios, and ecosystem platforms to drive innovation?
What does success look like for companies that don’t land billion-dollar out-licensing deals?
How can Chinese biotechs position themselves across the value chain to become attractive global partners?
When does it make sense for Chinese biopharmas to acquire overseas assets or companies?
🎤 Panelists:

Wu, Head of Development Strategy, Ops & AbbVie Ventures, China, AbbVie
Yuan, Head of Legal and Compliance, Duality Biologics
Yang, Head of External Innovation Asia Pacific, Novo Nordisk
Wang, Head of Innovation APAC, Johnson & Johnson
Li, Co-Head of Life Science Practice Group, Fangda Partners
Pitt, Global Head of Search, CSL Behring
🎙 Moderator:

Wang, CEO, PJ Partner Co., Ltd.

📌 Don’t miss this insightful panel discussion on sustainable partnership strategies and the future of biotech collaborations.

👉 Book your spot now! >> http://spr.ly/6186B6XASq

24/03/2026

🌟 Startup Spotlight Pitch Competition 🌟

We’re wrapping up Day 1 with an electrifying pitch competition showcasing the brightest startups in oncology, AI-driven drug discovery, immunology, modalities, and enabling technologies! 🚀

Our esteemed panel of judges—featuring top experts from VCs, pharma BD, and crossover investors—will provide live feedback on science, strategy, and partnering readiness.

🏆 What’s at stake?
The winner will receive:

A complimentary ticket to a future EBD Group event
Additional exciting prizes to be announced!
📅 When: Tuesday, 28 April 2026
🕒 Time: 15:30 - 17:00 CT (China Time, GMT+08:00)
📍 Where: Plenary Sessions

🎤 Meet the Judges:

Ying Niu – China Search and Evaluation Lead, Pfizer
Tam C. Nguyen – Director of Research & Innovation / IC Member, Monash Health / Horizon 3 Healthcare
Jia Zhuang – Executive Director, ATLATL Ventures
Yang Liu – Executive Director, Head, Lilly Gateway Labs China, Eli Lilly
💡 Don’t miss this chance to witness the next wave of biotech innovation in action!

👉 Book your spot now! >> http://spr.ly/6180B6X7CA

23/03/2026

🌟 Fireside Chat: Beyond the Buzz – AI in Biotech: Transformative or Incremental? 🌟

is the talk of the town in biopharma, but is it truly revolutionizing the industry or just evolving? Join us for an engaging session where top innovators and thought leaders debate AI's real-world impact on biotech and what lies ahead amidst tightening geopolitical restrictions.

📅 Date: Tuesday, 28 April 2026
⏰ Time: 13:30 - 14:00 CT (China Time, GMT+08:00)
📍 Session Type: Plenary

💡 Key Discussion Points:

Is AI genuinely accelerating drug discovery and development, or are we still in the early adoption phase?
How might U.S./China technology tensions impact biotech innovation?
What are the next meaningful AI breakthroughs in drug development?
How can investors and R&D leaders separate hype from scalable reality?
🎙️ Moderator:

Tam C. Nguyen, Director of Research & Innovation / IC Member, Monash Health / Horizon 3 Healthcare
🎤 Panelists:

Ren , Co-CEO & CSO, Insilico Medicine Ltd
Xiao, Partner, Morrison Foerster
Zhang, Head of AI & Data Compliance Group, Fangda Partners

👉 Don’t miss this thought-provoking discussion! Book your spot now and be part of the conversation shaping the future of AI in biotech. >> http://spr.ly/6184B6X20r

20/03/2026

🚨 Don’t Miss This Fireside Chat! 🚨

Regulation & Resilience: Keeping China Connected to the World 🌏

With evolving biosecurity rules, supply-chain scrutiny, and regulatory divergence, how can companies maintain global alignment? Join us as experts dive into the future of NMPA, FDA, and EMA compatibility and strategies for building resilient, compliant cross-border operations.

📅 Date: Tuesday, 28 April 2026
⏰ Time: 10:00 - 10:30 CT (China Time, GMT+08:00)
📍 Plenary Sessions

💡 Key Topics:
🔹 Future-proofing NMPA, FDA, and EMA alignment under new security laws.
🔹 Overcoming regulatory bottlenecks for global filings from China.
🔹 Leveraging China’s cost and speed advantages while supporting US/EU approvals.
🔹 Designing vendor and data strategies for long-term resilience.

🎙 Panelist: Lila Hope Partner, Cooley
🎤 Moderator: Yiming Liu, Partner, Cooley

📌 Book Now to secure your spot! >> http://spr.ly/6182B6XFzM

18/03/2026

🌟 Don’t miss this at ChinaBio™ Partnering Forum 2026! 🌟

📅 Session: Capital flows in flux: Navigating investment trends in 2026 and beyond
🕒 When: Tuesday, 28 April 2026, 14:00 - 15:00 CT (China Time, GMT+08:00)
📍 Plenary Sessions

Global market volatility is transforming biotech financing. Join this power-packed panel discussion featuring top VCs, strategic investors, and biotech CEOs as they explore:
🔹 The future of IPO windows for Chinese biotechs (onshore & offshore).
🔹 Alternative funding opportunities: royalty financings, project finance, revenue-sharing, and more.
🔹 The role of tokenization and digital structures in biotech financing.
🔹 How to craft a biotech story that resonates globally and demonstrates resilience.

💼 Panelists:

Matthieu Coutet , Partner, Sofinnova
Zhang, Partner, Innokylin Capital
Lin, Partner, Morrison Foerster
Ye, Executive Director, Head of Life Science & Healthcare, Shanghai Innovation Bank
🎤 Moderator:
Hong, Founding Partner, CEC Capital

📌 Secure your spot now! >> http://spr.ly/6189B6unth

16/03/2026

🌟 **Join Our Fireside Chat: "China Trials, Global Value" 🌟

With rising development costs and tighter US/EU capital markets, the global life sciences industry is turning to China as a key development hub. Discover how China’s clinical strengths—CRO expertise, patient access, and trial efficiency—are driving global Proof-of-Concept (PoC) studies and fostering ex-China partnerships.

📅 When: Wednesday, 29 April 2026
⏰ Time: 10:30 - 11:00 AM (China Time, GMT+08:00)
🎟️ Book Your Spot Now!

💡 Key Discussion Points:

Designing trial strategies to generate China data for US/EU filings.
The capabilities that make China trials valuable to Western partners.
How strong China PoC or Phase II data can improve deal terms and valuations.
Navigating regulatory challenges for NMPA/FDA/EMA alignment.
Running cost-effective trials in China while maintaining global governance.

🎤 Meet the Experts:

Derek Yuan , General Manager, China, Candid Therapeutics
Yu, Partner, Cooley
Moderator: Scott, President & CEO, Biocom
Don’t miss this opportunity to gain insights into leveraging China’s clinical strengths to accelerate global filings and deals.

👉 Reserve your spot today! >> http://spr.ly/6187B6PlDB

05/03/2026

🚨 Last Chance Alert! 🚨 You have 1 day left to save $700 on your ChinaBio™ Partnering Forum registration. The price break ends TOMORROW, March 6—don’t wait! 💼 Be part of the life sciences event of the year in China and connect with the brightest minds in the industry. 🔗 Register now before it’s too late >> http://spr.ly/6185h2hcX

04/03/2026

⏰ 2 Days Remaining! ⏰ This is your final chance to save $700 on your ChinaBio™ Partnering Forum registration. The price break ends on March 6—don’t let this opportunity slip away! 🌟 Join 1,000+ life sciences professionals and make meaningful connections that matter. 📢 Sign up now >> http://spr.ly/6186h2hOG

03/03/2026

🔥 3 Days Left to Save $700! 🔥 The countdown is on! Don’t miss out on the chance to attend ChinaBio™ Partnering Forum at the lowest price. The price break ends on March 6—act fast! 🤝 Connect with global leaders, explore new opportunities, and drive innovation in life sciences. 🎯 Register now >> http://spr.ly/6183h2Cb5

02/03/2026

⏳ 4 Days to Go! ⏳ Time is running out to save $700 on your ChinaBio™ Partnering Forum registration. Don’t wait until it’s too late—register before March 6 to lock in the best rate! 💡 Be part of the premier partnering event in China for the life sciences industry and take your business to the next level. 📅 Register today >> http://spr.ly/6186h27CM

02/03/2026

🌟 Share YOUR Startup Story at ChinaBio™ Partnering Forum! 🌟

The Startup Spotlight, sponsored by Pfizer, is your chance to pitch your innovations to top investors, pharma representatives, and industry leaders. Don’t miss this opportunity to shine on a global stage!

🚀 Highlights include:

Generate interest within the global life science audience.
Receive direct feedback from an expert panel of judges.
Win a complimentary registration to a future EBD event of your choice!
⏳ Hurry! Submit your application before the priority review deadline on Friday, March 6. Slots are filling up fast!

👉 Apply now: >> http://spr.ly/6180hvYgo

Adresse

KaufingerStr. 24
Munich
80331

Webseite

http://www.ebdgroup.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von EBD Group erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.